CYP2D6 phenotype determines the metabolic conversion of hydrocodone to hydromorphone
Otton, S V, Schadel, M, Cheung, S W, Kaplan, H L, Busto, U E, Sellers, E M
Published in Clinical pharmacology and therapeutics (01.11.1993)
Published in Clinical pharmacology and therapeutics (01.11.1993)
Get more information
Journal Article
Inhibition of Cytochrome P450 2D6 Metabolism of Hydrocodone to Hydromorphone Does Not Importantly Affect Abuse Liability
Kaplan, H L, Busto, U E, Baylon, G J, Cheung, S W, Otton, S V, Somer, G, Sellers, E M
Published in The Journal of pharmacology and experimental therapeutics (01.04.1997)
Get full text
Published in The Journal of pharmacology and experimental therapeutics (01.04.1997)
Journal Article
Clinical aspects of chronic use of alprazolam and lorazepam
Romach, M, Busto, U, Somer, G, Kaplan, H L, Sellers, E
Published in The American journal of psychiatry (01.08.1995)
Published in The American journal of psychiatry (01.08.1995)
Get more information
Journal Article
Comparative abuse liability of intravenously administered remifentanil and fentanyl
Baylon, G J, Kaplan, H L, Somer, G, Busto, U E, Sellers, E M
Published in Journal of clinical psychopharmacology (01.12.2000)
Published in Journal of clinical psychopharmacology (01.12.2000)
Get more information
Journal Article
A comparative pharmacokinetic and dynamic evaluation of alprazolam sustained-release, bromazepam, and lorazepam
Busto, U E, Kaplan, H L, Wright, C E, Gomez-Mancilla, B, Zawertailo, L, Greenblatt, D J, Sellers, E M
Published in Journal of clinical psychopharmacology (01.12.2000)
Published in Journal of clinical psychopharmacology (01.12.2000)
Get more information
Journal Article
Triazolam and ethanol interaction: kinetic and dynamic consequences
Dorian, P, Sellers, E M, Kaplan, H L, Hamilton, C, Greenblatt, D J, Abernethy, D
Published in Clinical pharmacology and therapeutics (01.05.1985)
Published in Clinical pharmacology and therapeutics (01.05.1985)
Get more information
Journal Article
Pharmacologic effects and abuse liability of bretazenil, diazepam, and alprazolam in humans
Busto, U, Kaplan, H L, Zawertailo, L, Sellers, E M
Published in Clinical pharmacology and therapeutics (01.04.1994)
Published in Clinical pharmacology and therapeutics (01.04.1994)
Get more information
Journal Article
Characteristics of long-term alprazolam users in the community
Romach, M K, Somer, G R, Sobell, L C, Sobell, M B, Kaplan, H L, Sellers, E M
Published in Journal of clinical psychopharmacology (01.10.1992)
Published in Journal of clinical psychopharmacology (01.10.1992)
Get more information
Journal Article
Inhibition of cytochrome P450 2A6 increases nicotine's oral bioavailability and decreases smoking
Sellers, E M, Kaplan, H L, Tyndale, R F
Published in Clinical pharmacology and therapeutics (01.07.2000)
Published in Clinical pharmacology and therapeutics (01.07.2000)
Get more information
Journal Article
Attenuation of the euphoric effects of cocaine by the dopamine D1/D5 antagonist ecopipam (SCH 39166)
Romach, M K, Glue, P, Kampman, K, Kaplan, H L, Somer, G R, Poole, S, Clarke, L, Coffin, V, Cornish, J, O'Brien, C P, Sellers, E M
Published in Archives of general psychiatry (01.12.1999)
Published in Archives of general psychiatry (01.12.1999)
Get more information
Journal Article
Acute kinetic and dynamic interactions of zimelidine with ethanol
Naranjo, C A, Sellers, E M, Kaplan, H L, Hamilton, C, Khouw, V
Published in Clinical pharmacology and therapeutics (01.11.1984)
Published in Clinical pharmacology and therapeutics (01.11.1984)
Get more information
Journal Article
Inhibition of cytochrome P450 2D6 modifies codeine abuse liability
Kathiramalainathan, K, Kaplan, H L, Romach, M K, Busto, U E, Li, N Y, Säwe, J, Tyndale, R F, Sellers, E M
Published in Journal of clinical psychopharmacology (01.08.2000)
Published in Journal of clinical psychopharmacology (01.08.2000)
Get more information
Journal Article